Storm Therapeutics

Storm RNA Epigenetics Conference

STORM Therapeutics Presents Breakthrough Data at RNA Epigenetics Conference.

18th September 2019

STORM Therapeutics presents breakthrough data showing in vivo efficacy and therapeutic proof of concept for targeting RNA modifying enzymes. 18 September 2019, Cambridge, UK.  STORM Therapeutics, the biotechnology company focused on the discovery of small molecule therapies modulating RNA epigenetics, […]

Read More
Home V2

Seroba Invests in Storm Therapeutics

20th May 2019

20 May 2019.  STORM Therapeutics (“STORM”), the drug discovery company tackling disease through modulating RNA modifying enzymes, has announced that it has raised an additional £14 million bringing its total Series A financing to £30 million. The financing includes funding […]

Read More
T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19
Ireland

Scroll to Top